454 related articles for article (PubMed ID: 12197624)
41. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
42. Menopause, mild psychological stress and salivary cortisol: influence of long-term hormone replacement therapy (HRT).
Patacchioli FR; Simeoni S; Monnazzi P; Pace M; Capri O; Perrone G
Maturitas; 2006 Sep; 55(2):150-5. PubMed ID: 16517104
[TBL] [Abstract][Full Text] [Related]
43. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
44. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
45. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
[TBL] [Abstract][Full Text] [Related]
46. Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy.
Song EK; Yeom JH; Shin HT; Kim SH; Shin WG; Oh JM
J Clin Pharm Ther; 2006 Oct; 31(5):421-7. PubMed ID: 16958819
[TBL] [Abstract][Full Text] [Related]
47. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
Pullerits R; d'Elia HF; Tarkowski A; Carlsten H
Rheumatology (Oxford); 2009 Jul; 48(7):785-90. PubMed ID: 19416946
[TBL] [Abstract][Full Text] [Related]
48. Periodontal aspects in menopausal women undergoing hormone replacement therapy.
López-Marcos JF; García-Valle S; García-Iglesias AA
Med Oral Patol Oral Cir Bucal; 2005; 10(2):132-41. PubMed ID: 15735546
[TBL] [Abstract][Full Text] [Related]
49. Intervertebral disc height in treated and untreated overweight post-menopausal women.
Baron YM; Brincat MP; Galea R; Calleja N
Hum Reprod; 2005 Dec; 20(12):3566-70. PubMed ID: 16113041
[TBL] [Abstract][Full Text] [Related]
50. Substrate utilization during exercise in postmenopausal women on hormone replacement therapy.
Johnson LG; Kraemer RR; Kraemer GR; Haltom RW; Cordill AE; Welsch MA; Durand RJ; Castracane VD
Eur J Appl Physiol; 2002 Dec; 88(3):282-7. PubMed ID: 12458372
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac functions in post-menopausal women: a randomized placebo controlled study.
Taskin O; Muderrisoglu H; Akar M; Simsek M; Mendilcioglu I; Kursun S
Maturitas; 2004 Aug; 48(4):354-9. PubMed ID: 15283927
[TBL] [Abstract][Full Text] [Related]
52. A short-term comparison of the effects of clomiphene citrate and conjugated equine estrogen in menopausal/castrate women.
Young RL; Goldzieher JW; Elkind-Hirsch K; Hickox PG; Chakraborty PK
Int J Fertil; 1991; 36(3):167-71. PubMed ID: 1678372
[TBL] [Abstract][Full Text] [Related]
53. Effects of estrogen/androgen therapy on bone mineral density parameters.
Notelovitz M
J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
[TBL] [Abstract][Full Text] [Related]
54. Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society.
Menopause; 1998; 5(2):69-76. PubMed ID: 9689198
[TBL] [Abstract][Full Text] [Related]
55. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women.
Skelton DA; Phillips SK; Bruce SA; Naylor CH; Woledge RC
Clin Sci (Lond); 1999 Apr; 96(4):357-64. PubMed ID: 10087242
[TBL] [Abstract][Full Text] [Related]
56. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
McCrohon JA; Adams MR; McCredie RJ; Robinson J; Pike A; Abbey M; Keech AC; Celermajer DS
Clin Endocrinol (Oxf); 1996 Oct; 45(4):435-41. PubMed ID: 8959082
[TBL] [Abstract][Full Text] [Related]
57. [Effect of suppletory estrogen or 1,25(OH)D3 on bone mineral content].
Amano K; Nemoto R; Kato Y; Masuda R; Nishijima M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):833-6. PubMed ID: 1500805
[TBL] [Abstract][Full Text] [Related]
58. [Menopause, hormone replacement treatment (HRT), stomatologic pathologies].
Pelissier A
Contracept Fertil Sex; 1998 Jun; 26(6):439-43. PubMed ID: 9691521
[TBL] [Abstract][Full Text] [Related]
59. Androgen replacement in menopause.
Burd ID; Bachmann GA
Curr Womens Health Rep; 2001 Dec; 1(3):202-5. PubMed ID: 12112971
[TBL] [Abstract][Full Text] [Related]
60. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study.
Shargil AA
Int J Fertil; 1985; 30(1):15, 18-28. PubMed ID: 2862116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
